Loading…

Intravenous anesthetic, propofol inhibits invasion of cancer cells

Intravenous anesthetic, propofol (2,6-diisopropylphenol), is extensively used for general anesthesia without knowing the effects on cancer. We found here that clinically relevant concentrations of propofol (1–5 μg/ml) decreased the invasion ability of human cancer cells (HeLa, HT1080, HOS and RPMI-7...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2002-10, Vol.184 (2), p.165-170
Main Authors: Mammoto, Tadanori, Mukai, Mutsuko, Mammoto, Akiko, Yamanaka, Yasutsugu, Hayashi, Yukio, Mashimo, Takashi, Kishi, Yoshihiko, Nakamura, Hiroyuki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intravenous anesthetic, propofol (2,6-diisopropylphenol), is extensively used for general anesthesia without knowing the effects on cancer. We found here that clinically relevant concentrations of propofol (1–5 μg/ml) decreased the invasion ability of human cancer cells (HeLa, HT1080, HOS and RPMI-7951). In the HeLa cells treated with propofol, formation of actin stress fibers as well as focal adhesion were inhibited, and propofol had little effect on the invasion ability of the HeLa cells with active Rho A (Val 14-Rho A). In addition, continuous infusion of propofol inhibited pulmonary metastasis of murine osteosarcoma (LM 8) cells in mice. These results suggest that propofol inhibits the invasion ability of cancer cells by modulating Rho A and this agent might be an ideal anesthetic for cancer surgery.
ISSN:0304-3835
1872-7980
DOI:10.1016/S0304-3835(02)00210-0